Home › Funds › Jones Hill Capital LP › CAPR
Jones Hill Capital LP position in CAPR
CAPRICOR THERAPEUTICS INC · Health Care
Jones Hill Capital LP reported holding 892,532 shares of CAPR (CAPRICOR THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 1.43% of its reported portfolio and ranking #20 among its reported holdings. Jones Hill Capital LP has disclosed CAPR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's CAPR position evolved
Jones Hill Capital LP first disclosed a stake in CAPR in Q1 2026 at 909,207 shares (US$27.6M). Across 3 filings, Jones Hill Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 892,532 shares valued at US$8.5M — an increase of 471,781 shares quarter over quarter.. Notable position changes include a 54% trim in Q2 2026 (shares fell 61% over the following quarter), a 112% increase in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 909.21K | $27.64M | New |
| Q2 2026 | 420.75K | $10.13M | Reduce |
| Q3 2026 | 892.53K | $8.45M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAPR and 13F data
CAPR (CAPRICOR THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in CAPR — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$98.7M), MONTANOVA CAPITAL, LLC (US$98.6M), RA CAPITAL MANAGEMENT, L.P. (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAPR
- TANG CAPITAL MANAGEMENT LLC 4.10M sh · $98.73M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.09M sh · $98.55M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.51M sh · $36.31M · Q2 2026
- Boxer Capital Management, LLC 1.40M sh · $33.60M · Q2 2026
- Soleus Capital Management, L.P. 761.74K sh · $18.34M · Q2 2026
- Ikarian Capital, LLC 350.00K sh · $8.43M · Q2 2026
- DIADEMA PARTNERS LP 329.30K sh · $7.93M · Q2 2026
- Palo Alto Investors LP 229.76K sh · $5.53M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held CAPR?
Jones Hill Capital LP has disclosed CAPR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Jones Hill Capital LP's current position in CAPR?
As of Q3 2026, Jones Hill Capital LP holds 892.53K shares of CAPR (CAPRICOR THERAPEUTICS INC), valued at $8.45M, representing 1.43% of its reported portfolio and ranking #20.
Has Jones Hill Capital LP been buying or selling CAPR?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP increased its position in CAPR.
Which other funds hold CAPR?
Other major institutional holders of CAPR include TANG CAPITAL MANAGEMENT LLC, MONTANOVA CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.